Literature DB >> 9195506

Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis.

W Swedler1, J Wallman, C J Froelich, M Teodorescu.   

Abstract

OBJECTIVE: To determine the isotype specificity and clinical utility of routine testing by ELISA of IgM, IgG, and IgA rheumatoid factors (RF).
METHODS: The test was performed on 619 individual specimens: blood bank donors (n = 130); rheumatoid arthritis (RA, n = 139); connective tissue diseases (CTD, n = 71); miscellaneous rheumatic disorders (MRD, n = 91); and 188 consecutive clinical laboratory specimens that tested positive by latex agglutination. Rabbit IgG was used as the antigen attached to the solid phase, and rabbit IgG antibody-enzyme conjugates against IgM (Fc5mu), IgG[F(ab')2], and IgA (alpha chain) were used, respectively, to detect IgM, IgG, and IgA RF. The serum was digested with pepsin to facilitate the measurement of IgG RF.
RESULTS: All 3 isotypes were specifically identified; IgM RF was destroyed by pepsin and IgG RF was specifically measured, without interference from IgA RF. Using data obtained from 98 RA specimens and 162 disease controls, the 3 main clinical variables--sensitivity, specificity, and predictive value--were stratified according to 3 combinations of RF isotypes: IgM only (91, 76, and 62%); IgM+IgA (79, 89, and 80%), and IgM+IgG+IgA (53, 99, and 96%). For patients with the 3 isotypes plus > 150 U of IgM and/or IgA the clinical variables were 70, 97, and 93%. In patients with RA the IgG RF was found only in association with IgM RF, i.e., there was no "hidden" RF, and IgA RF was always accompanied by IgM RF. There was a continuous decline in all 3 RF isotypes during treatment with gold salts. The sensitivity of ELISA for IgM RF exceeded that of nephelometry or latex agglutination.
CONCLUSION: Routine measurement of IgM, IgG, and IgA RF by ELISA with rabbit IgG as the antigen and pepsin digestion for the detection of IgG RF provides useful information in the differential diagnosis of patients with arthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195506

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Current methods for detecting antibodies against erythropoietin and other recombinant proteins.

Authors:  Robin Thorpe; Steven J Swanson
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

Review 2.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

3.  Predictive value of anti-citrullinated peptide antibodies: a real life experience.

Authors:  Abdulla Watad; Nancy Agmon-Levin; Boris Gilburd; Merav Lidar; Howard Amital; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

4.  Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors.

Authors:  S Bas; T V Perneger; E Kunzle; T L Vischer
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

5.  Rheumatoid factor measurement--continuing problems 70 years after discovery.

Authors:  Rohan Ameratunga; Samarina Musaad; Claudia Sugrue; Campbell Kyle
Journal:  Clin Rheumatol       Date:  2011-04-01       Impact factor: 2.980

6.  Effect of circulating immune complexes on the binding of rheumatoid factor to histones.

Authors:  H A Gussin; K L Russo; M Teodorescu
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

Review 7.  Autoantibodies and other serological markers in rheumatoid arthritis: predictors of disease activity?

Authors:  Licia Maria Henrique da Mota; Leopoldo Luiz dos Santos Neto; Jozélio Freire de Carvalho
Journal:  Clin Rheumatol       Date:  2009-07-14       Impact factor: 2.980

8.  High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.

Authors:  Francesca Bobbio-Pallavicini; Roberto Caporali; Claudia Alpini; Stefano Avalle; Oscar M Epis; Catherine Klersy; Carlomaurizio Montecucco
Journal:  Ann Rheum Dis       Date:  2006-11-01       Impact factor: 19.103

9.  Effect of tobacco smoking on tissue protein citrullination and disease progression in patients with rheumatoid arthritis.

Authors:  Mahmoud M Alsalahy; Hamdy S Nasser; Manal M Hashem; Sahar M Elsayed
Journal:  Saudi Pharm J       Date:  2010-02-20       Impact factor: 4.330

10.  Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis.

Authors:  Hemlata Das; Tatsuya Atsumi; Yukari Fukushima; Hitoshi Shibuya; Keiko Ito; Yuji Yamada; Yoshiharu Amasaki; Kenji Ichikawa; Olga Amengual; Takao Koike
Journal:  Clin Rheumatol       Date:  2004-02-26       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.